Higher affinity of the FcγRIIIA towards anti-cancer IgG has been achieved by modification of the Fc domain structure or Fc domain oligosaccharide content, which has resulted in higher ADCC responses of natural killer cells [33–35]. The gene discussed is FCGR3A; the disease is cancer.